Sentinel Node Detection in Endometrial Cancer: A Consolidation Study on Detection Rates of Metastatic Disease

Inclusion Criteria: * Women of age 18 years and older at the time of informed consent. * Women with a pathologically proven endometrial carcinoma of any histologic subtype or grade, clinically stage I-II planned for primary surgery * A uterine size allowing minimally invasive surgery * Women must be able to understand and sign an informed consent in Swedish language. * Absence of any exclusion criteria Exclusion Criteria: * Non consenting patients * Ongoing pregnancy * Inability to understand written and/or oral study information * WHO performance status or conditions contraindicating adjuvant oncological treatment (WHO III or more) * Previous lower limb lymphedema ( only for the lymphedema part of study) * Evidence of locally advanced disease or intraabdominal/distant metastases at preoperative CT, MRI or ultrasonography. * Surgical contraindication to a laparoscopic approach or lymphadenectomy at surgeons discretion. * Anesthesiologic contraindication to a laparoscopic approach at the anesthetist's discretion * Allergy to Iodine * Patients with a known liver disease * Patients with a bleeding disorder or mandatory antithrombotic treatment.